MRNY Performance — YieldMax MRNA Option Income Strategy ETF
Data updated: 2026-09-28
MRNY returned +58.25% year to date and +50.49% over one year to Jul 2026. Over one year the fund beat its US Large Blend category average: $100 grew to $150, against $116 for the category. Volatility over the past 12 months was 58.90% a year. In the 12 months to Jul 2026 the fund took in a net $42.5M, and assets reached $106.87M.
MRNY Growth of $100
What $100 invested in YieldMax MRNA Option Income Strategy ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | MRNY | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $150 | $116 |
| Since data start (Oct 2023 – Jul 2026) | $51 | $161 |
MRNY Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +58.25% |
| 1 year | +50.49% |
| 3 years (annualised) | −21.30% |
MRNY Annual Returns
Calendar-year total returns of YieldMax MRNA Option Income Strategy ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +58.25% |
| 2025 | −34.48% |
| 2024 | −59.33% |
| 2023 (Oct–Dec) | +20.28% |
MRNY Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +35.6% | +13.9% | −0.5% | −8.9% | +3.6% | +33.7% | −18.4% | — | — | — | — | — |
| 2025 | −10.2% | −19.4% | −8.1% | +0.1% | −3.5% | +5.0% | +2.0% | −16.8% | +5.6% | +6.2% | −4.4% | +6.7% |
| 2024 | −0.7% | −3.9% | +13.6% | +3.6% | −5.2% | −14.7% | +3.6% | −30.0% | −10.5% | −13.7% | −18.8% | −1.6% |
| 2023 | — | — | — | — | — | — | — | — | — | −3.2% | −1.1% | +25.7% |
MRNY Risk
Risk measures from monthly returns over Aug 2025 – Jul 2026.
- 1-year volatility (annualised): 58.90%
- Best month: +35.62% (Jan 2026)
- Worst month: −18.36% (Jul 2026)
MRNY Fund Flows
Monthly money in and out of YieldMax MRNA Option Income Strategy ETF, from SEC Form N-PORT.
- 12-month net flow: $42.5M
- 12-month gross sales (incl. reinvestments): $149.5M
- Sales ÷ redemptions: 1.40×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $20.8M | $0 | $20.8M |
| Jun 2026 | $21.9M | $8.5M | $13.4M |
| May 2026 | $2.5M | $5.9M | −$3.3M |
| Apr 2026 | $16.0M | $40.7M | −$24.7M |
| Mar 2026 | $41.0M | $3.4M | $37.6M |
| Feb 2026 | $4.8M | $901K | $3.9M |
| Jan 2026 | $12.9M | $10.4M | $2.5M |
| Dec 2025 | $5.5M | $16.7M | −$11.2M |
| Nov 2025 | $2.3M | $6.7M | −$4.4M |
| Oct 2025 | $4.0M | $5.9M | −$2.0M |
| Sep 2025 | $4.2M | $2.8M | $1.5M |
| Aug 2025 | $13.7M | $5.3M | $8.4M |
MRNY Assets Under Management
Net assets of YieldMax MRNA Option Income Strategy ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $106.87M |
| 2026-04-30 | $87.36M |
| 2026-01-31 | $90.38M |
| 2025-10-31 | $94.60M |
| 2025-07-31 | $115.27M |
| 2025-04-30 | $76.26M |
| 2025-01-31 | $70.52M |
| 2024-10-31 | $28.29M |
| 2024-07-31 | $31.33M |
| 2024-04-30 | $27.11M |
| 2024-01-31 | $20.89M |
| 2023-10-31 | $1.45M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.